Estrogens as potential therapeutic agents in multiple sclerosis.
about
The G-protein-coupled estrogen receptor GPER in health and diseaseEstrogen biology: new insights into GPER function and clinical opportunitiesWhat have we learned about GPER function in physiology and disease from knockout mice?GPER-targeted, 99mTc-labeled, nonsteroidal ligands demonstrate selective tumor imaging and in vivo estrogen binding.Raloxifene suppresses experimental autoimmune encephalomyelitis and NF-κB-dependent CCL20 expression in reactive astrocytes.Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis.Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination.Genetic and epigenetic underpinnings of sex differences in the brain and in neurological and psychiatric disease susceptibilityInternational Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic ModulatorsIcariin exerts estrogen-like activity in ameliorating EAE via mediating estrogen receptor β, modulating HPA function and glucocorticoid receptor expression.Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue.Multiple sclerosis and pregnancy: therapeutic considerations.Role of G protein-coupled orphan receptors in intestinal inflammation: novel targets in inflammatory bowel diseases.Effects of estrogen replacement therapy on the myelin sheath ultrastructure of myelinated fibers in the white matter of middle-aged ovariectomized rats.
P2860
Q27013052-601FA8B6-8AB8-46C2-BF06-10853E4096FEQ28307726-7ED5410A-5DE2-4135-A36D-71F1DBE483C1Q34485765-ABA5888A-8E03-4B00-8C0B-FB1AF1F73406Q34518285-0B6763C9-6892-47BE-A0CF-DEF67B56A90DQ35145298-3EBE9008-749D-4BDA-A63A-39AACD5446B6Q35164919-00C7BF91-EE23-4865-A6E9-49F7B4E62857Q35675723-6AA7D925-7B0F-4268-BAA6-AA5664820525Q35735221-C30311EE-7381-4B94-A7D8-53B2D8275573Q35795751-E43249BE-E1C3-4E04-8FB1-A19ABBE5CB87Q36879633-5933A1AB-9C12-43B7-84E5-4EA40EBBC5A4Q37703741-DDA63289-9ED4-4548-B941-613DE26D4041Q38038437-7AB2BD54-1E8F-4256-8FFE-AC7F50884499Q38280772-905C450B-AA38-48A4-A2D2-792046CF69E4Q47283993-874CD661-FB83-4F5C-96D9-8B540D98A54B
P2860
Estrogens as potential therapeutic agents in multiple sclerosis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Estrogens as potential therapeutic agents in multiple sclerosis.
@ast
Estrogens as potential therapeutic agents in multiple sclerosis.
@en
Estrogens as potential therapeutic agents in multiple sclerosis.
@nl
type
label
Estrogens as potential therapeutic agents in multiple sclerosis.
@ast
Estrogens as potential therapeutic agents in multiple sclerosis.
@en
Estrogens as potential therapeutic agents in multiple sclerosis.
@nl
prefLabel
Estrogens as potential therapeutic agents in multiple sclerosis.
@ast
Estrogens as potential therapeutic agents in multiple sclerosis.
@en
Estrogens as potential therapeutic agents in multiple sclerosis.
@nl
P2093
P1476
Estrogens as potential therapeutic agents in multiple sclerosis.
@en
P2093
Hidenao Sasaki
Makoto Hirotani
Masaaki Niino
Seiji Kikuchi
Toshiyuki Fukazawa
P356
10.2174/187152409788452054
P577
2009-06-01T00:00:00Z